Mass spectroscopy-based proteomics and metabolomics analysis of BT- 474 breast cancer cells treated with Tamoxifen and/or Trastuzumab
Ontology highlight
ABSTRACT: `Triple positive` BT-474 breast cancer cells were treated with anti-cancer compounds, Tamoxifen and Trastuzumab, and the metabolome and proteome analysed by LC-MS/MS using a timsTOF.
INSTRUMENT(S): timsTOF
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Epithelial Cell, Cell Culture
DISEASE(S): Breast Cancer
SUBMITTER: Alexander Giddey
LAB HEAD: Mohammad Semreen
PROVIDER: PXD033145 | Pride | 2023-01-17
REPOSITORIES: Pride
ACCESS DATA